In the AQP4-IgG era, five years after onset, less than 28% of NMO patients require a cane to walk, and less than 8% are wheelchair users.36Without treatment, ∼50% of patients with NMOSD will be wheelchair-dependent and functionally blind. Here, AQP4 is linked to neuromyelitis optica.